Merck KGaA
Merck KGaA is a global science and technology company that develops and manufactures pharmaceuticals, life science tools and reagents, and specialty chemicals for healthcare, biotech, academic, and industrial customers. It generates revenue through the sale of prescription medicines, laboratory and bioprocessing products, and performance materials used in electronics and other advanced industries. The company operates worldwide with a diversified portfolio across healthcare, life science, and electronics segments.
- Revenue
- $1B+
- Employees
- 5,001+
- Founded
- 1668
- Headquarters
- Darmstadt, Germany
Merck KGaA customers on Arbolus
Customers who reviewed Merck KGaA
Seniority of Merck KGaA customers
The largest group of people who reviewed Merck KGaA holds Director roles (45%), followed by C-Suite (30%) and Manager (25%).
- Director 45%
- C-Suite 30%
- Manager 25%
Customers sample
Employer names and spend open in the full report, along with the other 42 customers.
What 45 Arbolus experts think of Merck KGaA
Overall sentiment: Positive
NPS distribution is highly positive, with 67.4% Promoters, 25.6% Passives, and only 7% Detractors, resulting in an NPS score of 60.5. Renewal intent is strong, with 66.7% of respondents indicating they will renew and 0% indicating they will not. Stickiness is high, as 83.7% of customers have used Merck for more than one year. Expert feedback highlights Merck's critical role in manufacturing and regulatory support.
Everything 45 customers told us about Merck KGaA.
Employer names, spend, renewal intent and every written answer behind the numbers on this page.
Sentiment
57 Net Promoter Score, from 45 scored reviews- Promoters 30
- Passives 11
- Detractors 4
Praised
- Expansion of Manufacturing Services
- Critical Manufacturing Partner
Criticised
- Limited Weakness Data
- Limited Threat Data
What Merck KGaA customers say
Critical Manufacturing Partner
“I have relied on Merck's facilities as our main manufacturer for our portfolio pipeline, and their support has been essential for both adult and pediatric products since 2019.”
Expansion of Manufacturing Services
“I see potential for Merck to support more molecules and delivery formats, given their proven track record with our autoimmune products.”
Limited Weakness Data
“No significant weaknesses have emerged in my experience with Merck's manufacturing services.”
Renewal intent
Plan to renew 68%Plan to renew, by seniority
- 29% 7 answers
- 78% 9 answers
- 100% 6 answers
- 8.8/10 Average score from customers who will renew
- 8.1/10 Average score from undecided customers
Top alternatives
Most weighed by Merck KGaA customersReport
For people who use Merck KGaA
Do you use Merck KGaA at work?
Share your software review and get matched to paid projects. Arbolus pays you every time a client reads your review.
- 45 customers of Merck KGaA have already contributed
Takes a few minutes. Your identity stays anonymous.